Matches in SemOpenAlex for { <https://semopenalex.org/work/W4245344909> ?p ?o ?g. }
Showing items 1 to 64 of
64
with 100 items per page.
- W4245344909 endingPage "36" @default.
- W4245344909 startingPage "36" @default.
- W4245344909 abstract "To determine the magnitude of the decrease in the risk of retinopathy progression observed with intensive treatment and its relationship to baseline retinopathy severity and duration of follow-up.Randomized clinical trial, with 3 to 9 years of follow-up.Between 1983 and 1989, 29 centers enrolled 1441 patients with insulin-dependent diabetes mellitus aged 13 to 39 years, including 726 patients with no retinopathy and a duration of diabetes of 1 to 5 years (primary prevention cohort) and 715 patients with very mild to moderate nonproliferative diabetic retinopathy and a duration of diabetes of 1 to 15 years (secondary intervention cohort). Ninety-five percent of all scheduled examinations were completed.Intensive treatment consisted of the administration of insulin at least three times a day by injection or pump, with doses adjusted based on self-blood glucose monitoring and with the goal of normoglycemia. Conventional treatment consisted of one or two daily insulin injections.Change between baseline and follow-up visits on the Early Treatment Diabetic Retinopathy Study retinopathy severity scale, assessed with masked gradings of stereoscopic color fundus photographs obtained every 6 months.Cumulative 8.5-year rates of retinopathy progression by three or more steps at two consecutive visits were 54.1% with conventional treatment and 11.5% with intensive treatment in the primary prevention cohort and 49.2% and 17.1% in the secondary intervention cohort. At the 6- and 12-month visits, a small adverse effect of intensive treatment was noted (early worsening), followed by a beneficial effect that increased in magnitude with time. Beyond 3.5 years of follow-up, the risk of progression was five or more times lower with intensive treatment than with conventional treatment. Once progression occurred, subsequent recovery was at least two times more likely with intensive treatment than with conventional treatment. Treatment effects were similar in all baseline retinopathy severity subgroups.The results of the Diabetes Control and Complications Trial strongly support the recommendation that most patients with insulin-dependent diabetes mellitus use intensive treatment, aiming for levels of glycemia as close to the nondiabetic range as is safely possible." @default.
- W4245344909 created "2022-05-12" @default.
- W4245344909 date "1995-01-01" @default.
- W4245344909 modified "2023-10-18" @default.
- W4245344909 title "The Effect of Intensive Diabetes Treatment on the Progression of Diabetic Retinopathy in Insulin-Dependent Diabetes Mellitus" @default.
- W4245344909 doi "https://doi.org/10.1001/archopht.1995.01100010038019" @default.
- W4245344909 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7826293" @default.
- W4245344909 hasPublicationYear "1995" @default.
- W4245344909 type Work @default.
- W4245344909 citedByCount "276" @default.
- W4245344909 countsByYear W42453449092012 @default.
- W4245344909 countsByYear W42453449092013 @default.
- W4245344909 countsByYear W42453449092014 @default.
- W4245344909 countsByYear W42453449092015 @default.
- W4245344909 countsByYear W42453449092016 @default.
- W4245344909 countsByYear W42453449092017 @default.
- W4245344909 countsByYear W42453449092018 @default.
- W4245344909 countsByYear W42453449092019 @default.
- W4245344909 countsByYear W42453449092020 @default.
- W4245344909 countsByYear W42453449092021 @default.
- W4245344909 countsByYear W42453449092022 @default.
- W4245344909 countsByYear W42453449092023 @default.
- W4245344909 crossrefType "journal-article" @default.
- W4245344909 hasConcept C126322002 @default.
- W4245344909 hasConcept C134018914 @default.
- W4245344909 hasConcept C141071460 @default.
- W4245344909 hasConcept C201903717 @default.
- W4245344909 hasConcept C2778313320 @default.
- W4245344909 hasConcept C2779306644 @default.
- W4245344909 hasConcept C2779829184 @default.
- W4245344909 hasConcept C555293320 @default.
- W4245344909 hasConcept C71924100 @default.
- W4245344909 hasConcept C72563966 @default.
- W4245344909 hasConceptScore W4245344909C126322002 @default.
- W4245344909 hasConceptScore W4245344909C134018914 @default.
- W4245344909 hasConceptScore W4245344909C141071460 @default.
- W4245344909 hasConceptScore W4245344909C201903717 @default.
- W4245344909 hasConceptScore W4245344909C2778313320 @default.
- W4245344909 hasConceptScore W4245344909C2779306644 @default.
- W4245344909 hasConceptScore W4245344909C2779829184 @default.
- W4245344909 hasConceptScore W4245344909C555293320 @default.
- W4245344909 hasConceptScore W4245344909C71924100 @default.
- W4245344909 hasConceptScore W4245344909C72563966 @default.
- W4245344909 hasIssue "1" @default.
- W4245344909 hasLocation W42453449091 @default.
- W4245344909 hasLocation W42453449092 @default.
- W4245344909 hasOpenAccess W4245344909 @default.
- W4245344909 hasPrimaryLocation W42453449091 @default.
- W4245344909 hasRelatedWork W2028460579 @default.
- W4245344909 hasRelatedWork W2051860489 @default.
- W4245344909 hasRelatedWork W2059541234 @default.
- W4245344909 hasRelatedWork W2150699126 @default.
- W4245344909 hasRelatedWork W2152457997 @default.
- W4245344909 hasRelatedWork W2330998330 @default.
- W4245344909 hasRelatedWork W2401570230 @default.
- W4245344909 hasRelatedWork W3190746054 @default.
- W4245344909 hasRelatedWork W4297687594 @default.
- W4245344909 hasRelatedWork W943310924 @default.
- W4245344909 hasVolume "113" @default.
- W4245344909 isParatext "false" @default.
- W4245344909 isRetracted "false" @default.
- W4245344909 workType "article" @default.